Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $144.59 USD
Change Today +1.38 / 0.96%
Volume 997.9K
BDX On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

becton dickinson and co (BDX) Key Developments

Becton, Dickinson Reportedly Looks To Sell Respiratory Device Unit

Becton, Dickinson and Company (NYSE:BDX) is reportedly planning to sell its respiratory-devices unit according to people with knowledge of the matter. Becton, Dickinson is looking to sell unwanted assets following its acquisition of CareFusion Corp. “We’re conducting a strategic review of all of our businesses but haven’t made any decisions,” said Kristen Cardillo, a spokeswoman for Becton Dickinson.

Becton, Dickinson and Company and CareFusion Corporation Receives Clearance from the European Commission for the Pending Acquisition

Becton, Dickinson and Company and CareFusion Corporation announced that the companies have received clearance from the European Commission under the EU Merger Regulation for the pending acquisition of CareFusion by BD. The proposed acquisition has now received all necessary regulatory approvals. The proposed acquisition, which has been approved by CareFusion shareholders, remains subject to customary closing conditions. BD and CareFusion currently expect the proposed acquisition to close on March 17, 2015.

Becton, Dickinson and Company Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM

Becton, Dickinson and Company Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Christopher R. Reidy, Chief Financial Officer and Executive Vice President of Administration.

Becton, Dickinson and Company Announces Consolidated Unaudited Earnings Results for the First Quarter Ended December 31, 2014; Provides Earnings Guidance for the Full Year of Fiscal 2015

Becton, Dickinson and Company announced consolidated unaudited earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported revenues of $2,051 million compared with $2,015 million for the same period a year ago. Operating income was $349 million compared with $378 million for the same period a year ago. Income before tax was $236 million compared with $271 million for the same period a year ago. Net income was $236 million or $1.20 per diluted share compared with $271 million or $1.37 per diluted share for the same period a year ago. Adjusted diluted earnings per share was $1.53 compared with $1.43 for the same period a year ago. The company estimates that revenues for the full fiscal year 2015 will increase approximately 5.0% on a foreign currency-neutral basis, which is an increase from previously issued guidance of 4.5% to 5%. On a reported basis, revenues are expected to be about flat to a decline of 1.0%, due to the unfavorable impact of foreign currency. The company expects adjusted diluted earnings per share from continuing operations to grow 9.0% to 10.0% on a foreign currency-neutral basis. This is an increase from previously issued guidance of 8.0% to 9.0%. Including the estimated unfavorable impact of foreign-currency, adjusted diluted earnings per share are expected to be between $6.50 and $6.57. Adjusted diluted earnings per share for the full fiscal year 2014 were $6.50. The company expects full fiscal year reported diluted earnings per share from continuing operations to be between $5.98 to $6.05.

Becton, Dickinson and Company Declares Quarterly Cash Dividend, Payable on March 31, 2015

The Board of Directors of Becton, Dickinson and Company declared a quarterly dividend of 60 cents per common share, payable on March 31, 2015 to holders of record on March 10, 2015. The indicated annual dividend rate is $2.40 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BDX:US $144.59 USD +1.38

BDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,950 JPY -27.50
Avago Technologies Ltd $128.21 USD +3.50
Boston Scientific Corp $17.83 USD +0.39
Mylan NV $61.63 USD -0.25
Stryker Corp $92.56 USD +1.03
View Industry Companies
 

Industry Analysis

BDX

Industry Average

Valuation BDX Industry Range
Price/Earnings 24.8x
Price/Sales 3.3x
Price/Book 5.5x
Price/Cash Flow 26.3x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BECTON DICKINSON AND CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.